Characterization of myogenin expression in myotubes derived from quail myoblasts transformed with a temperature sensitive mutant of Rous sarcoma virus

Cell Structure and Function

Volumn 23, Issue 2, 1998, Pages 57-67

  Isobe, Akiko ^a   Hirayama, Etsuko ^a   Kim, Jeman ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

DNA synthesis; HMBA; Maturation of myofibrils; Myogenic differentiation; Myogenin

Indexed keywords

BROXURIDINE; HEXAMETHYLENEBISACETAMIDE; MYOGENIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; EMBRYO; MUSCLE FIBRIL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUAIL; ROUS SARCOMA ONCOVIRUS; TEMPERATURE SENSITIVE MUTANT; VIRUS CELL TRANSFORMATION;

EID: 0031877626     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.23.57     Document Type: Article

References (45)

1. ANDRES, V. and WALSH, K. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol., 132: 657-666.
2. BISCHOFF, R. 1978. Myoblast Fusion. In Membrane Fusion: Cell Surface Reviews (G. Poste and G.L. Nicolson, eds.). Elsevier Science Publishers B.V., Amsterdam, The Netherlands, pp. 127-179.
3. BRAUN, T., BUSCHHAUSEN-DENKER, G., BOBER, E., TANNICH, E., and ARNOLD, H.H. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J., 8: 701-709.
4. BRAUN, T., BOBER, E., WINTER, B., ROSENTHAL, N., and ARNOLD, H.H. 1990. Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J., 9: 821-831.
5. BRAUN, T., RUDNICKI, M.A., ARNOLD, H.H., and JAENISCH, R. 1992. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell, 71: 369-382.
6. BRAUN, T. and ARNOLD, H.H. 1995. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J., 14: 1176-1186.
7. CELIS, J.E. and MADSEN, P. 1994. Synchronization of transformed human amnion cells by mitotic detachment. In Cell Biol. (J.E. Cells, eds.). Academic press, Inc. San Diego, California, Vol.1, pp.288-293.
8. CRESCENZI, M., SODDU, S., and TATO, F. 1995. Mitotic cycle reactivation in terminally differentiated cells by adenovirus infection. J. Cell Physiol., 162: 26-35.
9. DAVIS, R.L., WEINTRAUB, H., and LASSAR, A.B. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell, 51: 987-1000.
10. EDMONDSON, D.G. and OLSON, E.N. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev., 3: 628-640.
11. EMERSON, C.P., JR. 1990. Myogenesis and developmental control genes. Curr. Opin. Cell Biol., 2: 1065-1075.
12. ENDO, T. and NADAL-GINARD, B. 1989. SV40 large T-antigen induces reentry of terminally differentiated myotubes into the cell cycle. In The Cellular and Molecular Biology of Muscle Development. (L.H. Kedes and F.E. Stockdale). Editors. Alan R. Liss, New York, pp.95-104.
13. FUJISAWA-SEHARA, A., NABESHIMA, Y., HOSODA, Y., OBINATA, T., and NABESHIMA, Y. 1990. Myogenin contains two domains conserved among myogenic factors. J. Biol. Chem., 265: 15219-15223.
14. HALEVY, O., NOVITCH, B.G., SPICER, D.B., SKAPEK, S.X., RHEE, J., HANNON, G.J., BEACH, D., and LASSAR, A.B. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science, 267: 1018-1021.
15. HASE, H., ISOBE, A., and KIM, J. 1995. Effect of orthovanadate on commitment of avian myoblasts transformed with Rous sarcoma virus to myogenic differentiation. Eur. J. Cell Biol., 68: 313-322.
16. HASE, H., HIRAYAMA, E., and KIM, J. 1996. Further investigation of some inhibitors on myogenic differentiation; mechanism of inhibition with HMBA on quail myoblasts transformed with Rous sarcoma virus. Cell, Struct. Funct., 21: 17-25.
17. HASTY, P., BRADLEY, A., MORRIS, J.H., EDMONDSON, D.G., VENUTI, J.M., OLSON, E.N., and KLEIN, W.H. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the Myogenin gene. Nature, 364: 501-506.
18. HIRAYAMA, E., HASE, H., NAKANO, Y., and KIM, J. 1995. Effects of some inhibitors on myogenic differentiation of avian myoblasts transformed with Rous sarcoma virus. Cell Struct. Funct., 20: 377-386.
19. HIRAYAMA, E., ISOBE, A., OKAMOTO, H., NISHIOKA, M., and KIM, J. 1997. Myogenin expression is necessary for commitment to differentiation and is closely related to src tyrosine kinase activity in quail myoblasts transformed with Rous sarcoma virus. Eur. J. Cell Biol., 72: 133-141.
20. HYODO, N. and KIM, J. 1994. Preparation and characterization of a monoclonal antibody that inhibits myoblast fusion of avian skeletal myoblasts. Exp. Cell Res., 212: 120-131.
21. IUJVIDIN, S., FUCHS, O., NUDEL, U., and YAFFE, D. 1990. SV40 immortalizes myogenic cells: DNA synthesis and mitosis in differentiating myotubes. Differentiation, 43: 192-203.
22. INOUE-HYODO, N. and KIM, J. 1997. Dynamic distribution of an antigen involved in differentiation of quail myoblasts transformed with Rous sarcoma virus: I. Requirement of its quantitative expression on cell surface for myoblast fusion. Cell Struct. Funct., 21: 515-534.
23. KAUFMAN, S.J. and FOSTER, R.F. 1988. Replicating myoblasts express a muscle-specific phenotype. Proc. Natl. Acad. Sci. USA, 85: 9606-9610.
24. KIM, J., ADACHI, T., HIRAYAMA, E., YABUBAYASHI, T., and OKADA, Y. 1992. Differentiation of quail myoblasts transformed with a temperature sensitive mutant of Rous sarcoma virus. I. Relationship between differentiation and tyrosine kinase of src gene product. Cell Struct. Funct., 17: 237-247.
25. KIM, J., ADACHI, T., SAIUCHI, M., and ASADA, A. 1992. Differentiation of quail myoblasts transformed with a temperature sensitive mutant of Rous sarcoma virus. II. Relationship of myoblast fusion with calcium and temperature. Cell Struct. Funct., 17: 249-255.
26. KIM, J., SAIUCHI, M., and ADACHI, T. 1995. Morphological characters and disturbance of myofibril assembly in avian myoblasts fused with HVJ (Sendai virus). Eur. J. Cell Biol., 66: 94-105.
27. KNUDSEN, K.A. and HORWITZ, A.F. 1977. Tandem events in myoblast fusion. Dev. Biol., 58: 328-338.
28. KONIGSBERG, I.R. 1963. Clonal analysis of myogenesis. Science, 140: 1273-1284.
29. LASSAR, A.B., BUSKIN, J.N., LOCKSHON, D., DAVIS, R.L., APONE, S., HAUSCHKA, S.D., and WEINTRAUB, H. 1989. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell, 58: 823-831.
30. MINER, J.H. and WOLD, B. 1990. Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc. Natl. Acad. Sci. USA, 87: 1089-1093.
31. MONTARRAS, D., PINSET, C., CHELLY, J., KAHN, A., and GROS, F. 1989. Expression of MyoD1 coincides with terminal differentiation in determined but inducible muscle cells. EMBO J., 8: 2203-2207.
32. MORRIS, G.E. and COLE, R.J. 1972. Cell fusion and differentiation in cultured chick muscle cells. Exp. Cell Res., 75: 191-199.
33. NABESHIMA, Y., HANAOKA, K., HAYASAKA, M., ESUM, E., LI, S., NONAKA, I., and NABESHIMA, Y. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature, 364: 532-535.
34. OKAZAKI, K. and HOLTZER, H. 1966. Myogenesis: Fusion, myosin synthesis, and the mitotic cycle. Proc. Natl. Acad. Sci. USA, 56: 1484-1490.
35. OLSON, E.N. and KLEIN, W.H. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev., 8: 1-8.
36. RHODES, S.J. and KONIECZNY, S.F. 1989. Identification of MRF4: a new member of the muscle regulatory factor gene family Genes Dev., 3: 2050-2061.
37. RUDNICKI, M.A., BRAUN, T., HINUMA, S., and JAENISCH, R. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell, 71: 383-390.
38. SAIUCHI, M., NUNOURA, N., and KIM, J. 1993. Preparation of a monoclonal antibody and expression of its antigen associated with myogenic differentiation on spontaneous and artificial myotubes derived from avian myoblasts. Cell Struct. Funct., 18: 285-296.
39. SCHNEIDER, J.W., GU, W., ZHU, L., MAHDAVI, V., and NADALGINARD, B. 1994. Reversal of terminal differentiation mediated by p107 in Rb - / - muscle cells. Science, 264: 1467-1471.
40. TANAKA, E.M., GANN, A.A., GATES, P.B., and BROCKES, J.P. 1997. Newt myotubes reenter the cell cycle by phosphorylation of the Retinoblastoma protein. J. Cell Biol., 136: 155-165.
41. WEINTRAUB, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell, 75: 1241-1244.
42. WEINTRAUB, H., DAVIS, R., TAPSCOTT, S., THAYER, M., KRAUSE, M., BENEZRA, R., BLACKWELL, T.K., TURNER, D., RUPP, R., HOLLENBERG, S., ZHUANG, Y., and LASSAR, A.B. 1991. The MyoD gene family: nodal point during specification of the muscle cell lineage. Science, 251: 761-766.
43. WRIGHT, W.E., SASSOON, D.A., and LIN, V.K. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell, 56: 607-617.
44. YAFFE, D. 1971. Developmental changes proceeding cell fusion during muscle differentiation in vitro. Exp. Cell Res., 66: 33-48.
45. ZHANG, W., BEHRINGER, R.R., and OLSON, E.N. 1995. Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev., 9: 1388-1399.